Epigenetics as a basis for diagnosis of neurodevelopmental disorders : challenges and opportunities
Neurodevelopmental disorders, such as autism, are complex entities that can be caused by biological and social factors. In a subset of patients with congenital neurodevelopmental disorders, clear diagnosis can be achieved using DNA sequence-based analysis to identify changes in the DNA sequence (genetic variation). However, it has recently become clear that changes to the secondary modifications of DNA and histone structures (epigenetic variation) can also cause neurodevelopmental disorders via alteration of neural gene function. Moreover, it has recently been demonstrated that epigenetic modifications are more susceptible to alterations induced by environmental factors than are DNA sequences, and that some drugs commonly used reverse mental-stress induced alterations to histone modifications in neural genes. Therefore, application of diagnostic assays to detect epigenetic alterations will provide new insight into the characterization and treatment of neurodevelopmental disorders.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2014 |
---|---|
Erschienen: |
2014 |
Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
---|---|
Enthalten in: |
Expert review of molecular diagnostics - 14(2014), 6 vom: 06. Juli, Seite 685-97 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kubota, Takeo [VerfasserIn] |
---|
Links: |
---|
Themen: |
DNA methylation |
---|
Anmerkungen: |
Date Completed 23.01.2015 Date Revised 18.06.2014 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1586/14737159.2014.925805 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM238927628 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM238927628 | ||
003 | DE-627 | ||
005 | 20231224114836.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2014 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1586/14737159.2014.925805 |2 doi | |
028 | 5 | 2 | |a pubmed24n0796.xml |
035 | |a (DE-627)NLM238927628 | ||
035 | |a (NLM)24902600 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kubota, Takeo |e verfasserin |4 aut | |
245 | 1 | 0 | |a Epigenetics as a basis for diagnosis of neurodevelopmental disorders |b challenges and opportunities |
264 | 1 | |c 2014 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 23.01.2015 | ||
500 | |a Date Revised 18.06.2014 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Neurodevelopmental disorders, such as autism, are complex entities that can be caused by biological and social factors. In a subset of patients with congenital neurodevelopmental disorders, clear diagnosis can be achieved using DNA sequence-based analysis to identify changes in the DNA sequence (genetic variation). However, it has recently become clear that changes to the secondary modifications of DNA and histone structures (epigenetic variation) can also cause neurodevelopmental disorders via alteration of neural gene function. Moreover, it has recently been demonstrated that epigenetic modifications are more susceptible to alterations induced by environmental factors than are DNA sequences, and that some drugs commonly used reverse mental-stress induced alterations to histone modifications in neural genes. Therefore, application of diagnostic assays to detect epigenetic alterations will provide new insight into the characterization and treatment of neurodevelopmental disorders | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a DNA methylation | |
650 | 4 | |a diagnosis | |
650 | 4 | |a epigenetics | |
650 | 4 | |a epigenome | |
650 | 4 | |a histone modification | |
650 | 4 | |a neurodevelopmental disorder | |
650 | 4 | |a treatment | |
650 | 7 | |a Histones |2 NLM | |
700 | 1 | |a Miyake, Kunio |e verfasserin |4 aut | |
700 | 1 | |a Hariya, Natsuyo |e verfasserin |4 aut | |
700 | 1 | |a Mochizuki, Kazuki |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Expert review of molecular diagnostics |d 2001 |g 14(2014), 6 vom: 06. Juli, Seite 685-97 |w (DE-627)NLM117852775 |x 1744-8352 |7 nnns |
773 | 1 | 8 | |g volume:14 |g year:2014 |g number:6 |g day:06 |g month:07 |g pages:685-97 |
856 | 4 | 0 | |u http://dx.doi.org/10.1586/14737159.2014.925805 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 14 |j 2014 |e 6 |b 06 |c 07 |h 685-97 |